# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-20-014754
Filing Date
2020-06-12
Accepted
2020-06-12 07:49:44
Documents
26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROSPECTUS | f424b40620_lanternpharm.htm | 424B4 | 4483701
2 | GRAPHIC | lantern_logo.jpg | GRAPHIC | 52886
3 | GRAPHIC | image_002.jpg | GRAPHIC | 1800056
4 | GRAPHIC | image_003.jpg | GRAPHIC | 584360
5 | GRAPHIC | image_004.jpg | GRAPHIC | 274908
6 | GRAPHIC | image_005.jpg | GRAPHIC | 788769
7 | GRAPHIC | image_005a.jpg | GRAPHIC | 653668
8 | GRAPHIC | image_007.jpg | GRAPHIC | 522130
9 | GRAPHIC | image_008.jpg | GRAPHIC | 569893
10 | GRAPHIC | image_009.jpg | GRAPHIC | 399932
11 | GRAPHIC | image_010.jpg | GRAPHIC | 559055
12 | GRAPHIC | image_011.jpg | GRAPHIC | 275395
13 | GRAPHIC | image_013.jpg | GRAPHIC | 52297
14 | GRAPHIC | image_014.jpg | GRAPHIC | 301519
15 | GRAPHIC | image_015.jpg | GRAPHIC | 424324
16 | GRAPHIC | image_016.jpg | GRAPHIC | 806461
17 | GRAPHIC | image_016a.jpg | GRAPHIC | 61921
18 | GRAPHIC | image_017.jpg | GRAPHIC | 417678
19 | GRAPHIC | image_018.jpg | GRAPHIC | 188581
20 | GRAPHIC | image_019.jpg | GRAPHIC | 265758
21 | GRAPHIC | image_020.jpg | GRAPHIC | 253741
22 | GRAPHIC | image_021.jpg | GRAPHIC | 86813
23 | GRAPHIC | image_022.jpg | GRAPHIC | 100389
24 | GRAPHIC | image_023.jpg | GRAPHIC | 264025
25 | GRAPHIC | image_024.jpg | GRAPHIC | 255793
26 | GRAPHIC | image_025.jpg | GRAPHIC | 62848
| Complete submission text file | 0001213900-20-014754.txt |  | 18178361

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-237714 | Film No.: 20958874
SIC: 2834 Pharmaceutical Preparations